Abstract
No public abstract is available from the verified source records.
Alex Choi, Alice Haystead, Rachel D'Cunha, John Hsu, Michael Zhu, Kim G. Johnson, Michael W. Lutz, Heather Whitson, Dilraj S. Grewal, Sharon Fekrat
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
New landscape of the diagnosis of Alzheimer's disease
10.1016/s0140-6736(25)01294-2 · 2025
Biomarker changes during 20 years preceding Alzheimer's disease
10.1056/nejmoa2310168 · 2024
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
10.1016/s1474-4422(20)30412-9 · 2021
Spectral-domain OCT measurements in Alzheimer's disease: a systematic review and meta-analysis
10.1016/j.ophtha.2018.08.009 · 2019
Changes in retinal microvasculature and retinal layer thickness in association with apolipoprotein E genotype in Alzheimer's disease
10.1038/s41598-020-80892-z · 2021
Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE e4 gene carriers
2021
Longitudinal analysis of the retina and choroid in cognitively normal individuals at higher genetic risk of Alzheimer disease
10.1016/j.oret.2022.03.001 · 2022
Retinal biomarkers for early Alzheimer's detection: a systematic review of optical coherence tomography (OCT) findings
10.1136/bmjophth-2025-002328 · 2026
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1002/alz.13859 · 2024
Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study
10.1001/jamaneurol.2018.1563 · 2018
Macular ganglion cell–inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and Alzheimers disease
10.1371/journal.pone.0162202 · 2016
Association between retinal thickness and ß-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
10.1186/s13195-020-00602-9 · 2020
Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease
10.1371/journal.pone.0192646 · 2018
Thicker macula in asymptomatic APOE e4 middle-aged adults at high AD risk
2022
Macular thickness decrease in asymptomatic subjects at high genetic risk of developing Alzheimer's disease: an OCT study
10.3390/jcm9061728 · 2020
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease
10.1186/s40478-025-01935-y · 2025
APOE4-driven lipid metabolic dysregulation in Alzheimer's disease: multi-pathway mechanisms and therapeutic perspectives
10.1016/j.bbrc.2025.152335 · 2025
Apolipoprotein E4 expression causes gain of toxic function in isogenic human induced pluripotent stem cell-derived endothelial cells
10.1161/atvbaha.118.312261 · 2019
APOE4, blood neurodegenerative biomarkers, and cognitive decline in community-dwelling older adults
10.1001/jamanetworkopen.2025.8903 · 2025
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease
10.1093/brain/awaa342 · 2020
Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET
10.1016/j.nbd.2024.106439 · 2024
Elevated cerebral blood flow proxy with increased beta-amyloid burden in Alzheimer's disease preclinical phase evaluated by dual-phase 18F-florbetaben positron emission tomography
10.1038/s41598-024-68916-4 · 2024
Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline
10.1177/0271678x20935171 · 2021
Compensatory retinal blood flow enhancement in cognitively normal ApoE e4 carriers
10.1038/s41598-025-16770-3 · 2025
APOE e4 gene carriers demonstrate reduced retinal capillary densities in asymptomatic older adults
10.3390/jcm12175649 · 2023
APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
10.1038/s41586-020-2247-3 · 2020
A “multi-omics” analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice
10.1084/jem.20221137 · 2022
Retinal microvascular changes in mild cognitive impairment and Alzheimer's disease: a systematic review, meta-analysis, and meta-regression
10.3389/fnagi.2022.860759 · 2022
Apolipoprotein E e4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: a mediation analysis of vascular contributions to cognitive decline
10.1002/alz.71000 · 2025
Retinal microvascular alterations in Alzheimer's disease: linking blood plasma biomarkers and cerebral small vessel pathology
10.1002/alz.70745 · 2025
Emerging oculomic signatures: linking thickness of entire retinal layers with plasma biomarkers in preclinical Alzheimer's disease
10.3390/jcm15010275 · 2025
Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease
10.1186/s13195-024-01668-5 · 2025
Ocular biomarkers for Alzheimer disease dementia: an umbrella review of systematic reviews and meta-analyses
10.1001/jamaophthalmol.2022.4845 · 2023
Diagnostic performance of plasma pTau217/Aß42 ratio and a three-zone threshold model for Alzheimer's disease
10.1016/j.neurobiolaging.2025.12.005 · 2026
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures
10.1038/s41591-021-01348-z · 2021
No additional external references are available.